InventionMed S.A. (WSE:INM)

InventionMed Statistics

Total Valuation

InventionMed has a market cap or net worth of PLN 26.16 million. The enterprise value is 26.11 million.

Market Cap	26.16M
Enterprise Value	26.11M

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

InventionMed has 202.79 million shares outstanding.

Current Share Class	201.79M
Shares Outstanding	202.79M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.61%
Owned by Institutions (%)	n/a
Float	113.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.46
PB Ratio	76.92
P/TBV Ratio	98.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.38
EV / Sales	11.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.50

Financial Position

The company has a current ratio of 0.09

Current Ratio	0.09
Quick Ratio	0.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.85

Financial Efficiency

Return on equity (ROE) is -157.45% and return on invested capital (ROIC) is -38.84%.

Return on Equity (ROE)	-157.45%
Return on Assets (ROA)	-1.62%
Return on Invested Capital (ROIC)	-38.84%
Return on Capital Employed (ROCE)	-4.16%
Revenue Per Employee	456,399
Profits Per Employee	-503,311
Employee Count	5
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.46% in the last 52 weeks. The beta is 0.16, so InventionMed's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	-27.46%
50-Day Moving Average	0.15
200-Day Moving Average	0.17
Relative Strength Index (RSI)	31.13
Average Volume (20 Days)	214,252

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InventionMed had revenue of PLN 2.28 million and -2.52 million in losses.

Revenue	2.28M
Gross Profit	2.04M
Operating Income	-993,268
Pretax Income	-2.52M
Net Income	-2.52M
EBITDA	-118,126
EBIT	-993,268
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 50,038 in cash and n/a in debt, giving a net cash position of 50,038 or 0.00 per share.

Cash & Cash Equivalents	50,038
Total Debt	n/a
Net Cash	50,038
Net Cash Per Share	0.00
Equity (Book Value)	340,085
Book Value Per Share	n/a
Working Capital	-13.10M

Cash Flow

In the last 12 months, operating cash flow was -1.55 million and capital expenditures -716,805, giving a free cash flow of -2.27 million.

Operating Cash Flow	-1.55M
Capital Expenditures	-716,805
Free Cash Flow	-2.27M
FCF Per Share	-0.01

Margins

Gross margin is 89.27%, with operating and profit margins of -43.53% and -110.28%.

Gross Margin	89.27%
Operating Margin	-43.53%
Pretax Margin	-110.28%
Profit Margin	-110.28%
EBITDA Margin	-5.18%
EBIT Margin	-43.53%
FCF Margin	n/a

Dividends & Yields

InventionMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.62%
FCF Yield	-8.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 6, 2022. It was a forward split with a ratio of 4.

Last Split Date	Sep 6, 2022
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	4